Xeomin is a Intramuscular Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Merz North America, Inc.. The primary component is Botulinum Toxin Type A.
Product ID | 46783-161_0e962a66-7cd9-4fde-b1d5-3ca29baec002 |
NDC | 46783-161 |
Product Type | Human Prescription Drug |
Proprietary Name | Xeomin |
Generic Name | Incobotulinumtoxina |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | INTRAMUSCULAR |
Marketing Start Date | 2011-08-01 |
Marketing Category | BLA / BLA |
Application Number | BLA125360 |
Labeler Name | Merz North America, Inc. |
Substance Name | BOTULINUM TOXIN TYPE A |
Active Ingredient Strength | 50 [USP'U]/1 |
Pharm Classes | Acetylcholine Release Inhibitor [EPC],Acetylcholine Release Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2011-08-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA125360 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2011-08-01 |
Ingredient | Strength |
---|---|
BOTULINUM TOXIN TYPE A | 50 [USP'U]/1 |
SPL SET ID: | 3f35d6e0-3450-4abc-a0da-cc7b277e7c6e |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0259-1605 | Xeomin | incobotulinumtoxinA |
0259-1610 | Xeomin | incobotulinumtoxinA |
0259-1620 | Xeomin | incobotulinumtoxinA |
0259-4110 | Xeomin | incobotulinumtoxinA |
0259-4150 | Xeomin | incobotulinumtoxinA |
46783-160 | Xeomin | incobotulinumtoxinA |
46783-161 | Xeomin | incobotulinumtoxinA |
46783-165 | Xeomin | Xeomin |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
XEOMIN 79371939 not registered Live/Pending |
Merz Pharma GmbH & Co. KGaA 2023-02-22 |
XEOMIN 77910865 3898981 Live/Registered |
MERZ PHARMA GmbH & Co. KGaA 2010-01-13 |
XEOMIN 76533879 2918539 Dead/Cancelled |
Merz Pharma GmbH & Co. KGaA 2003-08-01 |